

PreCision Dermatology: A Frazier Healthcare Partners Portfolio Company



ClosePrevious|NextPreCision DermatologyLeading prescription dermatology company with broad portfolio for acne and atopic dermatitisPreCision Dermatology was founded in 2010 as a spinout from fellow Frazier portfolio company Collegium Pharmaceutical.  The company started with three commercial-stage dermatology products based on the company's proprietary foam formulation technology. Over the next three years, the PreCision experienced tremendous growth through both internal R&D as well as a series of acquisitions to become one of the leading commercial prescription dermatology companies, with strong brands such as Locoid, Clindagel, Aurstat, and other products for acne and atopic dermatitis. PreCision was acquired by Valeant in 2014.
StatusAcquired by Valeant Pharmaceuticals in 2014Year of Investment2010StrategyLife SciencesSubsectorSpecialty PharmaceuticalsLocationNew York, New YorkFrazier TeamPatrick HeronDaniel Estes, Ph.D.Related NewsValeant Pharmaceuticals to Acquire Precision Dermatology for $475 Million


Insider Trading - Frazier Healthcare V Lp - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Frazier Healthcare V Lp





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-11-01Equity Swap
2016-11-035:26 pm
N/AN/A
Tobira Therapeutics Inc.
TBRA
Frazier Healthcare V Lp10% Owner
2,668,570
$28.35
0(Direct)
View


2015-06-30Conversion
2015-06-305:46 pm
N/AN/A
Glaukos Corp
GKOS
Frazier Healthcare V LpFhm V LLCEvery Nathan RFrazier Alan DNaini Nader JHeron Patrick JTopper James NFhm V Lp10% Owner
2,603,362
$0
2,603,362(Direct)
View


2015-06-30Conversion
2015-06-305:46 pm
N/AN/A
Glaukos Corp
GKOS
Frazier Healthcare V LpFhm V LLCEvery Nathan RFrazier Alan DNaini Nader JHeron Patrick JTopper James NFhm V Lp10% Owner
1,523,809
$0
2,603,362(Direct)
View


2015-06-30Conversion
2015-06-305:46 pm
N/AN/A
Glaukos Corp
GKOS
Frazier Healthcare V LpFhm V LLCEvery Nathan RFrazier Alan DNaini Nader JHeron Patrick JTopper James NFhm V Lp10% Owner
674,510
$0
2,603,362(Direct)
View


2015-06-30Conversion
2015-06-305:46 pm
N/AN/A
Glaukos Corp
GKOS
Frazier Healthcare V LpFhm V LLCEvery Nathan RFrazier Alan DNaini Nader JHeron Patrick JTopper James NFhm V Lp10% Owner
151,653
$0
2,603,362(Direct)
View


2015-06-30Conversion
2015-06-305:46 pm
N/AN/A
Glaukos Corp
GKOS
Frazier Healthcare V LpFhm V LLCEvery Nathan RFrazier Alan DNaini Nader JHeron Patrick JTopper James NFhm V Lp10% Owner
253,390
$0
2,603,362(Direct)
View


2015-06-26Exercise
2015-06-304:19 pm
N/AN/A
Glaukos Corp
GKOS
Frazier Healthcare V LpFhm V LLCEvery Nathan RFrazier Alan DNaini Nader JHeron Patrick JTopper James NFhm V Lp10% Owner
24,705
$7.65
674,510(Direct)
View


2015-06-26Exercise
2015-06-304:19 pm
2010-09-152017-09-15
Glaukos Corp
GKOS
Frazier Healthcare V LpFhm V LLCEvery Nathan RFrazier Alan DNaini Nader JHeron Patrick JTopper James NFhm V Lp10% Owner
24,705
$7.65
674,510(Direct)
View


2015-05-04Option Award
2015-05-069:12 pm
N/AN/A
Tibira Therapeutics Inc.
TBRA
Frazier Healthcare V Lp10% Owner
2,668,570
$0
2,668,570(Direct)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Fri, 28 Jul 2017 16:14:57 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  










Contact | Frazier Healthcare Partners



ContactSeattleTwo Union Square 601 Union Street, Suite 3200Seattle, WA 98101Phone: 206.621.7200Get DirectionsParking InstructionsMenlo Park70 Willow RoadSuite 200Menlo Park, CA 94025Phone: 650.325.5156Get Directions
  PEF1370 Quote - Frazier Healthcare V LP Fund - Bloomberg Markets                     



     Error: Could not add to watchlist. X   + Watchlist  Frazier Healthcare V LP   PEF1370:US      Inactive   PEF1370:US is inactive   USD             Fund Type   Private Equity Fund                  


                Before it's here, it's on the Bloomberg Terminal.
            

                Learn More
            

         Fund Type   Private Equity Fund    Objective   -    Asset Class Focus   Private Equity    Geographic Focus   -    NAV (on -)   -    Total Assets (-) (on -)   -    Inception Date   -    Last Dividend (on -)   -    Dividend Indicated Gross Yield   -    Fund Managers   -    Front Load Fee   -    Back Load Fee   -    Redemption Fee   -    12b-1 Fee   -    Current Mgmt Fee   -    Expense Ratio   -                     Profile   Frazier Healthcare V LP is a 2005 private equity fund currently harvesting. The Fund makes growth investments in the health care sector. The Fund makes investments within Canada and the United States.    Address  -   Phone  -   Website   -              

Firm | About  | Frazier Healthcare Partners



FirmDeep Domain ExpertiseWith over 750 collective years of investing in and operating healthcare companies, the Frazier team has experience with every aspect of building successful healthcare companies.Frazier Healthcare Partners was founded in 1991 as one of the first healthcare-focused investment firms. The firm has partnered with entrepreneurs in all stages of company growth, from company creation and venture capital to growth buyouts and leveraged recapitalizations. Frazier’s experienced team takes an active approach to helping build portfolio companies, leveraging the team’s deep domain expertise and expansive, global network of healthcare executives, advisors, and industry thought leaders.  
By The Numbers as of Q1 2017
Nearly $3.0B raised from 9 institutional funds
170+ healthcare portfolio companies 
16 years average tenure of General Partners at Frazier
35 portfolio companies gone public 
50 portfolio companies acquired

ONE FIRM: TWO STRATEGIESOver 26 years, Frazier Healthcare Partners has honed two primary but complementary strategies, each with a dedicated investment team.
Life SciencesThe Frazier Life Sciences team invests in and builds companies developing and commercializing novel therapeutics.Learn more about Frazier Life SciencesGrowth BuyoutThe firm’s Growth Buyout team invests in profitable companies focusing on healthcare services, pharmaceutical services, medical products, and related sectors.Learn more about Frazier Growth Buyout

Team | Frazier Healthcare Partners



Investment TeamFilter ResultsRefine by StrategyGrowth BuyoutLife SciencesRefine by RoleGeneral Partners Investment ProfessionalsVenture and Operating PartnersExecutive PartnersSenior AdvisorsOperationsOperating Professionals and Advisors are not full-time employees of Frazier Healthcare Partners, but provide advisory and consulting services to Frazier and often serve in operational positions within Frazier portfolio companies.

Portfolio | Frazier Healthcare Partners



PortfolioFilter ResultsRefine by StrategyGrowth BuyoutLife SciencesRefine by SectorAll PharmaceuticalsDevelopment-Stage TherapeuticsSpecialty PharmaceuticalsPharmaceutical ServicesAll Healthcare ServicesPayor/Payor ServicesProvider/Provider ServicesMedical Products & DistributionRefine by StatusCurrentPastView Complete Portfolio List

News | Frazier Healthcare Partners



NewsRecent News2017201620152014201320122011Interested in seeing more articles? Filter above for more.

Home | Frazier Healthcare Partners



Transforming HealthcareInvesting exclusively in healthcare for 26 yearsWith nearly $3.0B raised, Frazier Healthcare Partners is a leading provider of growth and venture capital to healthcare companies, focusing on Life Sciences and Growth Buyout investments.Life SciencesLearn more about Frazier Life SciencesAcquired by AstraZeneca in 2016IPO in 2017 (NASDAQ: ANAB)Acquired by Valeant Pharmaceuticals in 2014Acquired by Allergan in 2016Growth BuyoutLearn more about Frazier Growth BuyoutAcquired by The Partners GroupNewsPCIPharma Packager PCI Sells for More Than $1 BillionMatrix Medical NetworkProvidence Service Corporation and Frazier Healthcare Partners Complete Formation of Strategic Partnership in Matrix Medical NetworkPortola PharmaceuticalsU.S. FDA Approves Bevyxxa® (betrixaban) First and Only Anticoagulant for Hospital and Extended Duration Prevention of Venous Thromboembolism (VTE) in Acutely Ill Medical PatientsAlpine Immune SciencesAlpine Immune Sciences, Inc. Completes Merger with Nivalis Therapeutics, Inc.




SEC Info - Frazier Healthcare IV LP, et al. - ‘4’ for 6/27/07 re: Amicus Therapeutics Inc










SEC Info uses JavaScript!  To view pages properly, enable JavaScript in your browser.


    SEC Info      Home      Search      My Interests      Help      Sign In      Please Sign In




Frazier Healthcare IV LP, et al. – ‘4’ for 6/27/07 re: Amicus Therapeutics IncOn:  Friday, 6/29/07, at 9:59pm ET   ·   For:  6/27/07   ·   As:  10% Owner   ·   Accession #:  907303-7-117   ·   File #:  1-33497
Previous ‘4’:  ‘4’ on 6/7/07 for 6/5/07   ·   Next:  ‘4/A’ on 7/2/07 for 6/27/07   ·   Latest:  ‘4’ on 10/29/10 for 10/28/10



  in 
this entire Filing.
an "Entity" Search.
  Show 
Docs searched
 and 
every "hit".
the 1st "hit".

Help... Wildcards:  ? (any letter),  * (many).  Logic:  for Docs:  & (and),  | (or);  for Text:  | (anywhere),  "(&)" (near).    ↓Bottom
 
T-->  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 6/29/07  Frazier Healthcare IV LP          4          10% Owner   2:58K  Amicus Therapeutics Inc           Heller Ehrman LLP
          FHM V, LP
          Frazier Affiliates IV LP
          FHM V, LLC
          Frazier Healthcare V, LP
          FHM IV LPF-->Statement of Change in Beneficial Ownership of Securities   —   Form 4Filing Table of Contents
Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Change in Beneficial Ownership of      HTML     22K 
                          Securities --                                          
                          frazierform4062907f_ex.xml/2.2                         
 2: EX-99       Exhibit 99.1                                        HTML     28K 

D-->4   —   Statement of Change in Beneficial Ownership of Securities — frazierform4062907f_ex.xml/2.2
P-->

This document is an XML File that may be rendered in various formats:Form 4  –  Plain Text  –  EDGAR System  –  SEC Website  –  XML Listing  –  <?xml?> File  





FORM 4
UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange Act of 1934or Section 30(h) of the Investment Company Act of 1940


OMB APPROVAL




OMB Number:
3235-0287


Estimated average burden


hours per response:
0.5











  



Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See

Instruction 1(b).




1. Name and Address of Reporting Person*

FHM IV LP





(Last)
(First)
(Middle)




TWO UNION SQUARE


601 UNION STREET STE 3200


(Street)

SEATTLE
WA
98101





(City)
(State)
(Zip)



2. Issuer Name and Ticker or Trading Symbol
AMICUS THERAPEUTICS INC
[ FOLD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)


﻿
Director
X
10% Owner



﻿
Officer (give title below)

﻿
Other (specify below)



﻿





3. Date of Earliest Transaction
(Month/Day/Year) 6/27/07


4. If Amendment, Date of Original Filed
(Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)



﻿
Form filed by One Reporting Person


X
Form filed by More than One Reporting Person








Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned


1. Title of Security (Instr.
3)

2. Transaction Date
(Month/Day/Year)
2A. Deemed Execution Date, if any
(Month/Day/Year)
3. Transaction Code (Instr.
8)

4. Securities Acquired (A) or Disposed Of (D) (Instr.
3, 4 and 5)

5.
Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
3 and 4)

6. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)

7. Nature of Indirect Beneficial Ownership (Instr.
4)



Code
V
Amount
(A) or (D)
Price




Common Stock
 6/28/07

﻿
P

﻿
600
A
$11.48
149,734
I
By Frazier Healthcare V, LP (1) (3)


Common Stock
 6/28/07

﻿
P

﻿
1,900
A
$11.49
151,634
I
By Frazier Healthcare V, LP (1) (3)


Common Stock
 6/28/07

﻿
P

﻿
1,781
A
$11.5
153,415
I
By Frazier Healthcare V, LP (1) (3)


Common Stock
 6/29/07

﻿
P

﻿
120
A
$11.41
153,535
I
By Frazier Healthcare V, LP (1) (3)


Common Stock
 6/29/07

﻿
P

﻿
1,080
A
$11.42
154,615
I
By Frazier Healthcare V, LP (1) (3)


Common Stock
 6/29/07

﻿
P

﻿
980
A
$11.43
155,595
I
By Frazier Healthcare V, LP (1) (3)


Common Stock
 6/29/07

﻿
P

﻿
7
A
$11.44
155,602
I
By Frazier Healthcare V, LP (1) (3)


Common Stock
 6/29/07

﻿
P

﻿
890
A
$11.45
156,492
I
By Frazier Healthcare V, LP (1) (3)


Common Stock
 6/29/07

﻿
P

﻿
500
A
$11.46
156,992
I
By Frazier Healthcare V, LP (1) (3)


Common Stock
 6/29/07

﻿
P

﻿
700
A
$11.47
157,692
I
By Frazier Healthcare V, LP (1) (3)


Common Stock
 6/29/07

﻿
P

﻿
407
A
$11.48
158,099
I
By Frazier Healthcare V, LP (1) (3)


Common Stock
 6/29/07

﻿
P

﻿
5,236
A
$11.49
163,335
I
By Frazier Healthcare V, LP (1) (3)


Common Stock
 6/29/07

﻿
P

﻿
3,980
A
$11.5
167,315
I
By Frazier Healthcare V, LP (1) (3)


Common Stock

﻿

﻿

﻿

﻿

﻿

﻿

﻿
2,586,886
I
By Frazier Healthcare IV, LP (2) (3)


Common Stock

﻿

﻿

﻿

﻿

﻿

﻿

﻿
13,128
I
Frazier Affiliates IV, LP (2) (3)






Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned(e.g., puts, calls, warrants, options, convertible securities)


1. Title of Derivative Security (Instr.
3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date
(Month/Day/Year)
3A. Deemed Execution Date, if any
(Month/Day/Year)
4. Transaction Code (Instr.
8)

5.
Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
3, 4 and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Securities Underlying Derivative Security (Instr.
3 and 4)

8. Price of Derivative Security (Instr.
5)

9.
Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
4)

10. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)

11. Nature of Indirect Beneficial Ownership (Instr.
4)



Code
V
(A)
(D)
Date Exercisable
Expiration Date
Title
Amount or Number of Shares





1. Name and Address of Reporting Person*

FHM IV LP





(Last)
(First)
(Middle)




TWO UNION SQUARE


601 UNION STREET STE 3200


(Street)

SEATTLE
WA
98101





(City)
(State)
(Zip)





1. Name and Address of Reporting Person*

Frazier Healthcare V, LP





(Last)
(First)
(Middle)




601 UNION STREET, SUITE 3200


﻿


(Street)

SEATTLE
WA
98101





(City)
(State)
(Zip)





1. Name and Address of Reporting Person*

FHM V, LLC





(Last)
(First)
(Middle)




601 UNION STREET, SUITE 3200


﻿


(Street)

SEATTLE
WA
98101





(City)
(State)
(Zip)





1. Name and Address of Reporting Person*

FRAZIER AFFILIATES IV LP





(Last)
(First)
(Middle)




﻿


﻿


(Street)

﻿
﻿
﻿





(City)
(State)
(Zip)





1. Name and Address of Reporting Person*

FHM V, LP





(Last)
(First)
(Middle)




601 UNION STREET, SUITE 3200


﻿


(Street)

SEATTLE
WA
98101





(City)
(State)
(Zip)





1. Name and Address of Reporting Person*

FRAZIER HEALTHCARE IV LP





(Last)
(First)
(Middle)




﻿


﻿


(Street)

﻿
﻿
﻿





(City)
(State)
(Zip)







Explanation of Responses:


(1)  The securities are owned directly by Frazier Healthcare V, LP. FHM V, LP, a joint filer, serves as the general partner of Frazier Healthcare V, LP and FHM V, LLC, serves as the general partner of FHM V, LP. FHM V, LP and FHM V, LLC disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein.


(2)  The securities are owned directly by the entity listed. Frazier Healthcare IV, LP and Frazier Affiliates IV, LP, are joint filers. The designated filer, FHM IV, LP, serves as the general partner of Frazier Healthcare IV, LP and Frazier Affiliates IV, LP. FHM IV, LP disclaims beneficial ownership of the reported securities, except to the extent of its proportionate pecuniary interest therein.


(3)  There is no direct relationship among or between FHM V, LLC, FHM V, L.P. and Frazier Healthcare V, L.P., on the one hand, and FHM IV, LP, Frazier Healthcare IV, LP and Frazier Affiliates IV, LP, on the other. Beneficial ownership of Issuer shares as described herein and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the shares for purposes of Section 16 or for any other purpose.

Remarks:
Exhibit 99.1 - Joint Filer Information



﻿
FHM IV, LP By: FHM IV, LLC, its General Partner By: /s/ Thomas S. Hodge, Chief Operating Officer
 6/29/07



﻿
** Signature of Reporting Person
Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.


* If the form is filed by more than one reporting person,
see

Instruction
4

(b)(v).


** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See

18 U.S.C. 1001 and 15 U.S.C. 78ff(a).


Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see

Instruction 6 for procedure.


﻿




________Transaction Code:
    P:  Open market or private purchase of non-derivative or derivative security.
↑TopFiling Submission 0000907303-07-000117   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2017 Fran Finnegan & Company.  All Rights Reserved.About – Privacy – Redactions – Help —
Fri, 28 Jul 21:14:57.0 GMT 




Frazier Healthcare V, LP  - Current Holdings - Fintel.io

































Frazier Healthcare V, LP 







Current Holdings (from 13F, 13D)


InvestorFrazier Healthcare V, LP 
Current Positions1


Frazier Healthcare V, LP  has disclosed 1 total holdings in their latest SEC filings.
        
        
            
                This investor has not filed a 13F, which indicates it has under $100M in Assets Under Management (AUM).
            
        
        
            This investor has filed 2 activist 13D filings recently, which suggests it
            takes an active role in influencing management.

        
        
        
        
            Frazier Healthcare V, LP 's top industries are
            
                "Chemicals And Allied Products" (sic 28)
                ,
                 and 
            
                "Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks" (sic 38)
                
                
            .
        
    

Overview
SEC Filings
13D/13G
Predictive Value









All Frazier Healthcare V, LP  holdings are listed in the following table.
                This data is sourced from 13D/13G, and 13F filings. Green rows indicate new positions. Red rows indicate closed positions.



Add This Fundto your dashboard



This is a list of 13D and 13G filings made since the last quarterly 13F report (if any).



File DateFormSecurity

PrevShares
CurrentShares
Change(Percent)
Prev Value(x$1000)
Current Value(x$1000)
Change(Percent)




2017‑02‑14
SC 13G/A
GKOS / Glaukos Corp.

*
2,603,362







2017‑02‑10
SC 13D
ANAB / AnaptysBio, Inc.

*

3,688,447






2016‑11‑03
SC 13D/A
TBRA / Tobira Therapeutics, Inc.

*
2,668,570







2016‑03‑08
SC 13G/A
ZLTQ / ZELTIQ Aesthetics, Inc.

*


















Fintel IR - Find the Right Investors for Your Company, Instantly!
        Fintel IR combines the comprehensive Fintel ownership database with machine learning to
        provide advanced tools to make investor outreach fast and easy.
        Learn more now!
















Become a power user!

 Join our private investing channel!
Request Membership




























FRAZIER HEALTHCARE V, LP Form ADV Details as of 2017-02-06  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















WhaleWisdom /
Filer Search /
FRAZIER HEALTHCARE V, LP /
Form ADV Filing



Quick Nav

Top
Identifying Info
SEC Registration
Organization
Advisory Business
Clients
Compensation
AUM
Advisory Activites
Other Business
Custody
Disclosures



Form ADV Compilation Report
FRAZIER HEALTHCARE V, LP
Compilation done on 2017-02-06

Item 1 Identifying Information


A.


   Your full legal name (if you are a sole proprietor, your last, first, and middle names):





FRAZIER MANAGEMENT, L.L.C.




B.


   Name under which you primarily conduct your advisory business, if different from Item 1.A. 





FRAZIER HEALTHCARE




D.


   your SEC file number:





801-81162




E.


   If you have a number (“CRD Number”) assigned by the FINRA’s CRD system or by the IARD system, your CRD number





157324





    Principal Office and Place of Business
  




   601 UNION STREET
          SUITE 3200
      SEATTLE
      WA  98101
  






   Telephone number at this location:





206-621-7200







   Facsimile number at this location:





206-621-1848





      Mailing Address
    









I


   Do you have one or more websites?






 Yes
 No







HTTPS://WWW.FRAZIERHEALTHCARE.COM





M


   Are you registered with a foreign financial regulatory authority?





  Yes
  No





N


   Are you a public reporting company under Sections 12 or 15(d) of the Securities Exchange Act of 1934?





  Yes
  No





O


   Did you have $1 billion or more in assets on the last day of your most recent fiscal year?





  Yes
  No




Item 2 SEC Registration

To register (or remain registered) with the SEC, you must check at least one of the Items 2.A.(1) through
    2.A.(12), below. If you are submitting an annual updating amendment to your SEC registration and you
    are no longer eligible to register with the SEC, check Item 2.A.(13). Part 1A Instruction 2 provides
    information to help you determine whether you may affirmatively respond to each of these items.
    :
You (the adviser)


(1)




    are a large advisory firm
    




(2)




    are a mid-sized advisory firm
    




(3)




    have your principal office and place of business in Wyoming
    




(4)




    have your principal office and place of business outside the United States
    




(5)




    are an investment adviser (or sub-adviser) to an investment company registered under the Investment Company Act of 1940
    




(6)




    are an investment adviser to a company which has elected to be a business development
    company
    




(7)




    are a pension consultant with respect to assets of plans having an aggregate value of at least
    $200,000,000 that qualifies for the exemption in rule 203A-2(a)
    




(8)




    are a related adviser under rule 203A-2(b)
    




(9)




    ) are a newly formed adviser relying on rule 203A-2(c) because you expect to be eligible for SEC
    registration within 120 days;
    




(10)




    are a multi-state adviser that is required to register in 15 or more states and is relying on rule
    203A-2(d); 
    




(11)




    are an Internet adviser relying on rule 203A-2(e);
    




(12)




    have received an SEC order exempting you from the prohibition against registration with the
    SEC;
    




(13)




    are no longer eligible to remain registered with the SEC.
    


SEC Reporting by Exempt Reporting Advisors


(1)




    qualify for the exemption from registration as an adviser solely to one or more venture capital
    funds;
    




(2)




    qualify for the exemption from registration because you act solely as an adviser to private funds
    and have assets under management in the United States of less than $150 million;
    




(3)




    act solely as an adviser to private funds but you are no longer eligible to check box 2.B.(2)
    because you have assets under management in the United States of $150 million or more.
    


State Securities Authority Notice Filings and State Reporting by Exempt Reporing Advisors


C


   Under state laws, SEC-registered advisers may be required to provide to state securities authorities a copy
    of the Form ADV and any amendments they file with the SEC. These are called notice filings. In addition,
    exempt reporting advisers may be required to provide state securities authorities with a copy of reports and
    any amendments they file with the SEC. If this is an initial application or report, check the box(es) next to
    the state(s) that you would like to receive notice of this and all subsequent filings or reports you submit to
    the SEC. If this is an amendment to direct your notice filings or reports to additional state(s), check the
    box(es) next to the state(s) that you would like to receive notice of this and all subsequent filings or reports
    you submit to the SEC. If this is an amendment to your registration to stop your notice filings or reports
    from going to state(s) that currently receive them, uncheck the box(es) next to those state(s). 











CA
WA




Item 3 Form of Organization


A


   How are you organized:





Limited Liability Company 




B


   In what month does your fiscal year end each year? 





DECEMBER




C


   Under the laws of what state or country are you organized?





DE  United States



Item 5 Information About Your Advisory Business


A


   Approximately how many employees do you have? Include full- and part-time employees but do not
     include any clerical workers.





15




B (1)


   Approximately how many of the employees reported in 5.A. perform investment advisory functions
    (including research)? 





12




(2)


   Approximately how many of the employees reported in 5.A. are registered representatives of a brokerdealer?





0




(3)


   Approximately how many of the employees reported in 5.A. are registered with one or more state
    securities authorities as investment adviser representatives? 





0




(4)


   Approximately how many of the employees reported in 5.A. are registered with one or more state
    securities authorities as investment adviser representatives for an investment adviser other than you? 





0




(5)


   Approximately how many of the employees reported in 5.A. are licensed agents of an insurance
    company or agency? 





0




(6)


   Approximately how many firms or other persons solicit advisory clients on your behalf? 





0



Clients


C (1)


   To approximately how many clients did you provide investment advisory services during your most
     recently completed fiscal year? 





11-25 




(2)


   Approximately what percentage of your clients are non-United States persons?





23




D (1)


   What types of clients do you have? Indicate the approximate percentage that each type of client
    comprises of your total number of clients. If a client fits into more than one category, check all
    that apply.









(a)


   Individuals (other than
    high net worth individuals) 





0 percent




(b)


   High net worth individuals





0 percent




(c)


   Banking or thrift institutions





0 percent




(d)


   Investment companies 





0 percent




(e)


   Business development companies





0 percent




(f)


   Pooled investment vehicles (other than
     investment companies)





100 percent




(g)


   Pension and profit sharing plans
     (but not the plan participants)





0 percent




(h)


   Charitable organizations 





0 percent




(i)


   Corporations or other businesses
     not listed above





0 percent




(j)


   State or municipal government entities





0 percent




(k)


   Other investment advisers





0 percent




(l)


   Insurance companies 





0 percent




(m)


   Other:





0 percent 




D (2)


   Indicate the approximate amount of your regulatory assets under management (reported in Item 5.F.
    below) attributable to each of the following type of client. If a client fits into more than one category,
    check all that apply









(a)


   Individuals (other than
        high net worth individuals) 





0 percent




(b)


   High net worth individuals





0 percent




(c)


   Banking or thrift institutions





0 percent




(d)


   Investment companies 





0 percent




(e)


   Business development companies





0 percent




(f)


   Pooled investment vehicles (other than
         investment companies)





More than 75 percent




(g)


   Pension and profit sharing plans
         (but not the plan participants)





0 percent




(h)


   Charitable organizations 





0 percent




(i)


   Corporations or other businesses
         not listed above





0 percent




(j)


   State or municipal government entities





0 percent




(k)


   Other investment advisers





0 percent




(l)


   Insurance companies 





0 percent




(m)


   Other:





0 percent 



Compensation Arrangements


E


   You are compensated for your investment advisory services by (check all that apply): 









(1)




    A percentage of assets under your management
    




(2)




    Hourly charges
    




(3)




    Subscription fees (for a newsletter or periodical)
    




(4)




    Fixed fees (other than subscription fees) 
    




(5)




    Commissions 
    




(6)




    Performance-based fees
    




(7)




    Other
    



Regulatory Assets Under Management


F (1)


   Do you provide continuous and regular supervisory or management services to securities
     portfolios? 






 Yes
 No





F (2) (a)


   If yes, what is the amount of your regulatory assets under management?  Discretionary





2454779773.0




F (2) (b)


   If yes, what is the amount of your regulatory assets under management?  Non-Discretionary





0.0




F (2) (c)


   If yes, what is the amount of your regulatory assets under management?  Total





0.0




F (2) (d)


   If yes, what is the total number of accounts?  Discretionary





13




F (2) (e)


   If yes, what is the total number of accounts?  Non-Discretionary





0




F (2) (f)


   If yes, what is the total number of accounts?  Total





13



Advisory Activities


G


   What type(s) of advisory services do you provide? Check all that apply. 









(1)




    Financial planning services 
    




(2)




    Portfolio management for individuals and/or small businesses 
    




(3)




    Portfolio management for investment companies (as well as “business development companies”
     that have made an election pursuant to section 54 of the Investment Company Act of 1940) 
    




(4)




    Portfolio management for pooled investment vehicles (other than investment companies) 
    




(5)




    Portfolio management for businesses (other than small businesses) or institutional clients
    (other than registered investment companies and other pooled investment vehicles) 
    




(6)




    Pension consulting services
    




(7)




    Selection of other advisers (including private fund managers)
    




(8)




    Publication of periodicals or newsletters 
    




(9)




    Security ratings or pricing services 
    




(10)




    Market timing services 
    




(11)




    Educational seminars/workshops
    




(12)




    Other
    




H


   If you provide financial planning services, to how many clients did you provide these services during your
    last fiscal year?












   If more than 500, how many?









I


   If you participate in a wrap fee program, do you (check all that apply): 









(1)




    sponsor the wrap fee program?
    




(2)




    act as a portfolio manager for the wrap fee program?
    




J


   In response to Item 4.B. of Part 2A of Form ADV, do you indicate that you provide investment advice only
    with respect to limited types of investments? 






 Yes
 No




Item 6 Other Business Activities


A


   You are actively engaged in business as a (check all that apply):









(1)




    broker-dealer (registered or unregistered)
    




(2)




    registered representative of a broker-dealer
    




(3)




    commodity pool operator or commodity trading advisor (whether registered or exempt from
    registration)
    




(4)




    futures commission merchant
    




(5)




    real estate broker, dealer, or agent 
    




(6)




    insurance broker or agent 
    




(7)




    bank (including a separately identifiable department or division of a bank) 
    




(8)




    trust company
    




(9)




    registered municipal advisor
    




(10)




    registered security-based swap dealer
    




(11)




    major security-based swap participant
    




(12)




    accountant or accounting firm 
    




(13)




    lawyer or law firm
    




(14)




    other financial product salesperson
    




B (1)


   Are you actively engaged in any other business not listed in Item 6.A. (other than giving investment
     advice)?





  Yes
  No





B (2)


   If yes, is this other business your primary business?





  Yes
  No





B (3)


   Do you sell products or provide services other than investment advice to your advisory clients?





  Yes
  No



Item 7 Financial Industry Affiliations and Private Fund Reporting


A


   This part of Item 7 requires you to provide information about you and your related persons, including
    foreign affiliates. Your related persons are all of your advisory affiliates and any person that is under
    common control with you.
    You have a related person that is a (check all that apply): 









(1)




    broker-dealer, municipal securities dealer, or government securities broker or dealer
    




(2)




    other investment adviser (including financial planners) 
    




(3)




    registered municipal advisor
    




(4)




    registered security-based swap dealer
    




(5)




    major security-based swap participant 
    




(6)




    commodity pool operator or commodity trading advisor (whether registered or exempt from
    registration) 
    




(7)




    futures commission merchant
    




(8)




    banking or thrift institution 
    




(9)




    trust company
    




(10)




    accountant or accounting firm
    




(11)




     lawyer or law firm 
    




(12)




    insurance company or agency
    




(13)




    pension consultant 
    




(14)




    real estate broker or dealer
    




(15)




    sponsor or syndicator of limited partnerships (or equivalent), excluding pooled
    investment vehicles 
    




(16)




    sponsor, general partner, managing member (or equivalent) of pooled investment vehicles
    




B.


   Are you an adviser to any private fund?






 Yes
 No



Item 8 Participation or Interest in Client Transactions


A. (1)


   Do you or any related person: buy securities for yourself from advisory clients, or sell securities you own to
     advisory clients (principal transactions)? 






 Yes
 No





(2)


   Do you or any related person: buy or sell for yourself securities (other than shares of mutual funds) that you
    also recommend to advisory clients?






 Yes
 No





(3)


   Do you or any related person: recommend securities (or other investment products) to advisory clients in
    which you or any related person has some other proprietary (ownership)
    interest (other than those mentioned in Items 8.A.(1) or (2))?





  Yes
  No





B. (1)


   Do you or any related person: as a broker-dealer or registered representative of a broker-dealer, execute
    securities trades for brokerage customers in which advisory client securities
    are sold to or bought from the brokerage customer (agency cross transactions)?





  Yes
  No





(2)


   Do you or any related person: recommend purchase of securities to advisory clients for which you or any related
        person serves as underwriter, general or managing partner, or purchaser representative?






 Yes
 No





(3)


   recommend purchase or sale of securities to advisory clients for which you or any
        related person has any other sales interest (other than the receipt of sales
        commissions as a broker or registered representative of a broker-dealer)?





  Yes
  No





C


   Do you or any related person have discretionary authority to determine the:









(1)


   securities to be bought or sold for a client’s account?






 Yes
 No





(2)


   amount of securities to be bought or sold for a client’s account?






 Yes
 No





(3)


   broker or dealer to be used for a purchase or sale of securities for a client’s account?






 Yes
 No





(4)


   commission rates to be paid to a broker or dealer for a client’s securities
    transactions?






 Yes
 No





D


   If you answer “yes” to C.(3) above, are any of the brokers or dealers related persons?





  Yes
  No





E


   Do you or any related person recommend brokers or dealers to clients?





  Yes
  No





F


   If you answer “yes” to E above, are any of the brokers or dealers related persons?





  Yes
  No





G (1)


   Do you or any related person receive research or other products or services
    other than execution from a broker-dealer or a third party (“soft dollar benefits”) in
    connection with client securities transactions?





  Yes
  No





(2)


   If "yes" to G.(1) above, are all the “soft dollar benefits” you or any
    related persons receive eligible “research or brokerage services” under section
    28(e) of the Securities Exchange Act of 1934?





  Yes
  No





H


   Do you or any related person, directly or indirectly, compensate any person for
    client referrals?





  Yes
  No





I


   Do you or any related person, directly or indirectly, receive compensation from any
    person for client referrals?





  Yes
  No




Item 9 Custody


A (1)


   Do you have custody of any advisory clients’ cash or bank accounts?:





  Yes
  No





(2)


   Do you have custody of any advisory clients’ securities?:





  Yes
  No





(2) (a)


   If you checked “yes” to Item 9.A.(1)(a) or (b), what is the approximate amount of client funds and securities for which you have custody:









(2) (b)


   If you checked “yes” to Item 9.A.(1)(a) or (b), what is the total number of clients for which you have custody::









B (1)


   In connection with advisory services you provide to clients, do any of your related persons have
    custody of any of your advisory clients’ cash or bank accounts?:






 Yes
 No





(2)


   In connection with advisory services you provide to clients, do any of your related persons have
        custody of any of your advisory clients’ securities?:






 Yes
 No





(2) (a)


   If you checked “yes” to Item 9.A.(1)(a) or (b), what is the approximate amount of client funds and securities for which your related persons have custody:





1588170000.0




(2) (b)


   If you checked “yes” to Item 9.A.(1)(a) or (b), what is the total number of clients for which your related persons have custody::





13




C


   If you or your related persons have custody of client funds or securities in connection with advisory services you provide to clients, check all the following that apply:









(1)




    A qualified custodian(s) sends account statements at least quarterly to the investors in the pooled investment vehicle(s) you manage.
    




(2)




    An independent public accountant audits annually the pooled investment vehicle(s) that you manage and the audited financial statements are distributed to the investors in the pools.
    




(3)




    An independent public accountant conducts an annual surprise examination of client funds and securities.
    




(4)




    An independent public accountant prepares an internal control report with respect to custodial services when you or your related persons are qualified custodians for client funds and securities.
    




D


   Do you or your related person(s) act as qualified custodians for your clients in connection with advisory services you provide to clients?









(1)


   you act as a qualified custodian





  Yes
  No





(2)


   your related person(s) act as qualified custodian(s)





  Yes
  No





E


   If you are filing your annual updating amendment and you were subject to a surprise examination by an
    independent public accountant during your last fiscal year, provide the date (MM/YYYY) the examination commenced:









F


   If you or your related persons have custody of client funds or securities, how many persons, including,
     but not limited to, you and your related persons, act as qualified custodians for your clients in connection with advisory services you provide to clients?





4


Item 10 Control Persons


A


   Does any person not named in Item 1.A. or Schedules A, B, or C, directly or indirectly, control your management or policies?





  Yes
  No




Item 11 Disclosure Information





   Do any of the events below involve you or any of your supervised persons?





  Yes
  No





A. (1)


   In the past ten years, have you or any advisory affiliate: been convicted of or pled guilty or nolo contendere (“no contest”) in a
    domestic, foreign, or military court to any felony?





  Yes
  No





A. (2)


   In the past ten years, have you or any advisory affiliate: been charged with any felony?





  Yes
  No





B. (1)


   been convicted of or pled guilty or nolo contendere (“no contest”) in a domestic,
    foreign, or military court to a misdemeanor involving: investments or an
    investment-related business, or any fraud, false statements, or omissions,
    wrongful taking of property, bribery, perjury, forgery, counterfeiting, extortion,
    or a conspiracy to commit any of these offenses?





  Yes
  No





B. (2)


   been charged with a misdemeanor listed in Item 11.B.(1)?





  Yes
  No





C


   Has the SEC or the Commodity Futures Trading Commission (CFTC) ever:









 (1)


   found you or any advisory affiliate to have made a false statement or omission?





  Yes
  No





 (2)


   found you or any advisory affiliate to have been involved in a violation of SEC
    or CFTC regulations or statutes?





  Yes
  No





 (3)


   found you or any advisory affiliate to have been a cause of an investment-related
    business having its authorization to do business denied, suspended, revoked, or
    restricted?





  Yes
  No





 (4)


   entered an order against you or any advisory affiliate in connection with
    investment-related activity?





  Yes
  No





 (5)


   imposed a civil money penalty on you or any advisory affiliate, or ordered you
    or any advisory affiliate to cease and desist from any activity?





  Yes
  No





D


   Has any other federal regulatory agency, any state regulatory agency, or any foreign
    financial regulatory authority:









 (1)


   ever found you or any advisory affiliate to have made a false statement or
        omission, or been dishonest, unfair, or unethical?





  Yes
  No





 (2)


   ever found you or any advisory affiliate to have been involved in a violation of
        investment-related regulations or statutes?





  Yes
  No





 (3)


   ever found you or any advisory affiliate to have been a cause of an investment-
        related business having its authorization to do business denied, suspended,
        revoked, or restricted?





  Yes
  No





 (4)


   in the past ten years, entered an order against you or any advisory affiliate in
        connection with an investment-related activity?





  Yes
  No





 (5)


   ever denied, suspended, or revoked your or any advisory affiliate’s registration or
        license, or otherwise prevented you or any advisory affiliate, by order,
        from associating with an investment-related business or restricted your or any
        advisory affiliate’s activity?





  Yes
  No





E


   Has any self-regulatory organization or commodities exchange ever:









 (1)


   found you or any advisory affiliate to have made a false statement or omission?





  Yes
  No





 (2)


   found you or any advisory affiliate to have been involved in a violation of its
         rules (other than a violation designated as a “minor rule violation” under a plan
         approved by the SEC)?





  Yes
  No





 (3)


   found you or any advisory affiliate to have been the cause of an investment-
         related business having its authorization to do business denied, suspended,
         revoked, or restricted?





  Yes
  No





 (4)


   disciplined you or any advisory affiliate by expelling or suspending
         you or the advisory affiliate from membership, barring or suspending you or
         the advisory affiliate from association with other members, or otherwise
         restricting your or the advisory affiliate’s activities?





  Yes
  No





F


   Has an authorization to act as an attorney, accountant, or federal contractor granted
    to you or any advisory affiliate ever been revoked or suspended?





  Yes
  No





G


   Are you or any advisory affiliate now the subject of any regulatory proceeding that
    could result in a “yes” answer to any part of Item 11.C., 11.D., or 11.E.?





  Yes
  No





H (1)


   Has any domestic or foreign court:









 (a)


   in the past ten years, enjoined you or any advisory affiliate in connection with any
             investment-related activity?





  Yes
  No





 (b)


   ever found that you or any advisory affiliate were involved in a violation of
             investment-related statutes or regulations?





  Yes
  No





 (c)


   ever dismissed, pursuant to a settlement agreement, an investment-related
             civil action brought against you or any advisory affiliate by a state or foreign
             financial regulatory authority?





  Yes
  No





 (2)


   Are you or any advisory affiliate now the subject of any civil proceeding that could
    result in a “yes” answer to any part of Item 11.H(1)?





  Yes
  No











Elevate your investments
Try it for free
















Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft











Frazier Healthcare V, LP - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











Frazier Healthcare V, LP
Check out list of companies and businesses related to Frazier Healthcare V, LP. Find out Frazier Healthcare V, LP address and contact details. View other people related to Frazier Healthcare V, LP - coworkers, colleagues, companions, etc.
Address:   

601 UNION STREET, SUITE 3200  SEATTLE 98101 WA




Companies related to Frazier Healthcare V, LP
CIKCompany NamePositionCompany Address0000920465LA JOLLA PHARMACEUTICAL CO10182 TELESIS COURT, 6TH FLOOR  SAN DIEGO 921210001003464ENDOCARE INC10% Owner 201 TECHNOLOGY DRIVE  IRVINE 926180001178879AMICUS THERAPEUTICS INC1 CEDAR BROOK DRIVE  CRANBURY 085120001192448GLAUKOS Corp10% Owner 229 AVENIDA FABRICANTE  SAN CLEMENTE 926720001311596Tobira Therapeutics, Inc.10% Owner 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO 940800001333248CADENCE PHARMACEUTICALS INC10% Owner 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO 921300001370053ANAPTYSBIO INC10% Owner 10421 PACIFIC CENTER COURT, SUITE 200  SAN DIEGO 921210001415336Zeltiq Aesthetics Inc10% Owner 4410 ROSEWOOD DRIVE  Pleasanton 94588




Frazier Healthcare V, LP on the Web
Persons related to Frazier Healthcare V, LP - LA JOLLA PHARMACEUTICAL CONamePositionCityTHOMAS PHD  ADAMSDirector SAN DIEGOBRUCE K  BENNETT JRVP of Manufacturing SAN DIEGOLIANG  BERTRANDSAN DIEGOBIOMARIN PHARMACEUTICAL INC10% Owner NOVATOJENNIFER  CARVERChief Operating Officer SAN DIEGONIV EDWARD  CAVIARChief Business Officer & CFO SAN DIEGOLakhmir S  ChawlaChief Medical Officer SAN DIEGOZYGMONT,  CHESTER IIISAN DIEGOGILLESPIE  DEIRDRESAN DIEGOLaura L.  DouglassDirector SAN DIEGOLaura L.  DouglassDirector SAN DIEGOJosefina T  ElchicoVP Quality Operations SAN DIEGOWILLIAM  ENGBERSDirector SAN DIEGOSTEVEN B  ENGLECEO & Chairman SAN DIEGOESSEX WOODLANDS HEALTH VENTURES FUND VI L P10% Owner THE WOODLANDSESSEX WOODLANDS HEALTH VENTURES FUND VI L P10% Owner THE WOODLANDSESSEX WOODLANDS HEALTH VENTURES FUND VII LP10% Owner THE WOODLANDSFHM V, LLCSEATTLEFHM V, LLCSEATTLEFHM V, LLCSEATTLEFHM V, LPSEATTLEFHM V, LPSEATTLEFHM V, LPSEATTLEROBERT PHD  FILDESDirector SAN DIEGOROBERT PHD  FILDESDirector SAN DIEGOSLOAN  GAILSAN DIEGOTIDMARSH  GEORGESAN DIEGODeirdre  GillespiePresident & CEO SAN DIEGODeirdre  GillespiePresident & CEO SAN DIEGOAlejandro  Gonzalez10% Owner MEXICO D.F.Alejandro  Gonzalez10% Owner CHAPULTEPEC MORALES, MEXICOAlejandro  Gonzalez10% Owner Alejandro  Gonzalez10% Owner MEXICO D.F.Alejandro  Gonzalez10% Owner MEXICO D.F.KENNETH R  HEILBRUNNVP of Clinical Development SAN DIEGOROLKE  JAMESSAN DIEGOPAUL  JENNVP of Product Development SAN DIEGOCraig A  JohnsonDirector LA JOLLACraig A  JohnsonDirector SAN DIEGOCraig A  JohnsonDirector SAN DIEGOLISA I  KOCHVP Regulatory & Project Mgmt. SAN DIEGOBertrand C.  LiangSAN DIEGOMATTHEW D  LINNIKCSO & Exec VP of Research SAN DIEGOSTEPHEN  MARTINDirector SAN DIEGOSTEPHEN  MARTINDirector SAN DIEGODENNIS  MULROYChief Financial Officer SAN DIEGONader J  NainiDirector SEATTLETEDDI  REILLYVP of Human Resources SAN DIEGORichard  ReinischBALLWINWILLIAM R  RINGODirector SAN DIEGOFILDES  ROBERTSAN DIEGOJames  RolkeChief Scientific Officer SAN DIEGORobert  RosenDirector REDWOOD CITYRobert  RosenDirector SAN DIEGOSTACEY  RUIZSAN DIEGOZARRABIAN  SAIIDSAN DIEGOLUKE  SEIKKULAVice President Manufacturing SAN DIEGOGAIL A  SLOANVP of Finance SAN DIEGOGAIL A  SLOANChief Financial Officer SAN DIEGOCRAIG R  SMITHDirector SAN DIEGOMARTIN  STEPHENSAN DIEGOMARTIN P  SUTTERDirector THE WOODLANDSMARTIN P  SUTTERDirector THE WOODLANDSMARTIN P  SUTTERDirector THE WOODLANDSTANG CAPITAL MANAGEMENT LLCSAN DIEGOTANG CAPITAL MANAGEMENT LLCSAN DIEGOTANG CAPITAL MANAGEMENT LLCSAN DIEGOTANG CAPITAL PARTNERS LPSAN DIEGOTANG CAPITAL PARTNERS LPSAN DIEGOTANG CAPITAL PARTNERS LPSAN DIEGOKEVIN C  TANGDirector KEVIN C  TANGSAN DIEGOKEVIN C  TANGDirector SAN DIEGOMICHAEL JAMES BYRON  TANSEYExecutive VP & CMO SAN DIEGOW LEIGH MD PHD  THOMPSON SAN DIEGOGEORGE F  TIDMARSHPresident, CEO & Secretary REDWOOD CITYGEORGE F  TIDMARSHPresident, CEO & Secretary SAN DIEGOGEORGE F  TIDMARSHPres, CEO, Sec'y SAN DIEGOGEORGE F  TIDMARSHPresident and CEO SAN DIEGOGEORGE F  TIDMARSHPresident and CEO SAN DIEGOGEORGE F  TIDMARSHSAN DIEGOGEORGE F  TIDMARSHPresident, CEO & Secretary SAN DIEGOJames N  TopperDirector SEATTLEJames N  TopperDirector MENLO PARKWILLIAM J  WELCHVP Sales & Marketing SAN DIEGOANDREW  WISEMANSen Dir Investor Relations SAN DIEGOFRANK  YOUNGDirector BETHESDASaiid  ZarrabianDirector PATTERSONSaiid  ZarrabianDirector SAN DIEGOSaiid  ZarrabianDirector SAN DIEGOSaiid  ZarrabianDirector SAN DIEGOPersons related to Frazier Healthcare V, LP - ENDOCARE INCNamePositionCityDANE  ANDREEFF10% Owner BATON ROUGEDANE  ANDREEFF10% Owner SANTA ROSA BEACHDANE  ANDREEFF10% Owner SANTA ROSA BEACHANDREEFF EQUITY ADVISORS, LLCSANTA ROSA BEACHANDREEFF EQUITY ADVISORS, LLCSANTA ROSA BEACHPETER F  BERNARDONIDirector EL DORADO HILLSPETER F  BERNARDONIDirector EL DORADO HILLSROBERT F  BYRNESDirector HAYWARDJOHN R  DANIELSPACIFIC PALISADESJOHN R  DANIELSDirector IRVINEJOHN R  DANIELS IRVINECRAIG T  DAVENPORTIRVINECRAIG T  DAVENPORTChairman, CEO and President IRVINEClint  DavisGeneral Counsel IRVINEFHM V, LLCSEATTLEFHM V, LPSEATTLEBENJAMIN  GERSONDirector PHILADELPHIADAVID L  GOLDSMITHDirector IRVINEDAVID L  GOLDSMITHDirector IRVINEHEALTHTRONICS, INC.AUSTINERIC S  KENTORDirector IRVINEERIC S  KENTOR IRVINERONALD A  MATRICARIADirector NORTH OAKSTERRENCE A  NOONANInterim CEO/President IRVINEWILLIAM J  NYDAMPresident & COO IRVINEKEVIN M  QUILTY IRVINEMichael R  RodriguezSr. VP and CFO IRVINEMichael R  RodriguezIRVINEMichael R  RodriguezSVP, Finance & CFO IRVINEMichael R  RodriguezSVP, Finance & CFO IRVINEMICHAEL J MD  STRAUSSDirector ROCKVILLEMICHAEL J MD  STRAUSSDirector IRVINETHOMAS R  TESTMANDirector IRVINETHOMAS R  TESTMAN IRVINEPersons related to Frazier Healthcare V, LP - AMICUS THERAPEUTICS INCNamePositionCityBarkas  AlexanderCranburyKurt J.  AndrewsSVP, Human Resources CRANBURYWilliam D  Baird IIIChief Financial Officer CRANBURYMark  BaldryVP Global Marketing CRANBURYJOHN V  BALENWESTPORTSOL J  BARERDirector WARRENSOL J  BARERDirector CRANBURYSOL J  BARERDirector SUMMITALEXANDER E  BARKASDirector PALO ALTOM JAMES  BARRETTBALTIMOREM JAMES  BARRETTDirector TIMONIUMPETER J  BARRIS10% Owner BALTIMOREPETER J  BARRIS10% Owner TIMONIUMJay  BarthChief Medical Officer CRANBURYFOREST  BASKETTBALTIMOREFOREST  BASKETTTIMONIUMStephen M  BlochDirector WESTPORTStephen M  BlochDirector WESTPORTStephen M  BlochDirector WESTPORTPol F  BoudesChief Medical Officer CRANBURYPol F  BoudesChief Medical Officer CRANBURYCampbell  BradleyCranburyCampbell  BradleyCranburyDouglas A  BranchCRANBURYBradley L  CampbellChief Operating Officer CRANBURYBradley L  CampbellChief Operating Officer CRANBURYCANAAN EQUITY III ENTREPRENEURS LLCWESTPORTCANAAN EQUITY III LPWESTPORTCanaan Equity Partners III LLC10% Owner WESTPORTJeff  CastelliSVP, Program Management CRANBURYCHL Medical Partners II, L.P.10% Owner STAMFORDCHL Medical Partners II Side Fund, L.P.10% Owner STAMFORDWheeler  CraigCranburyJohn F  CrowleyChairman & CEO CRANBURYJohn F  CrowleyChairman & CEO CRANBURYQuimi  DaphneCranburyAllsop  DavidSVP International CRANBURYLockhart  DavidCranburyLockhart  DavidCranburyKAMRA  DEEPAKWESTPORTJames E  DentzerChief Financial Officer CRANBURYJames E  DentzerChief Financial Officer CRANBURYEnrique  DiloneSVP, Technical Operations CRANBURYEnrique  DiloneVP, Technical Operations CRANBURYHung  DoChief Science Officer CRANBURYHayden  DonaldCranburyHayden, Jr.  DonaldCranburyDipal  DoshiSVP Strategy & Bus Dev CRANBURYRYAN D  DRANTBALTIMORERYAN D  DRANTTIMONIUMJOSEPH  EDELMANJOSEPH  EDELMANNEW YORKJOSEPH  EDELMANNEW YORKDilone  EnriqueCranburyROBERT  ESSNERDirector MADISONROBERT  ESSNERDirector CRANBURYFHM IV LP10% Owner SEATTLEFHM IV LP10% Owner SEATTLEFHM V, LLCSEATTLEFHM V, LPSEATTLEFRAZIER AFFILIATES IV LPFRAZIER AFFILIATES IV LPSEATTLEFRAZIER HEALTHCARE IV LPSEATTLEFRAZIER HEALTHCARE IV LPGarden State Life Sciences Venture Fund L P10% Owner PHILADELPHIAGilmore  GeoffreyCranburyJayne  GershkowitzSVP, Chief Patient Advocate CRANBURYGeoffrey  GilmoreSVP & General Counsel CRANBURYPLC  GLAXOSMITHKLINE10% Owner BRENTFORD MIDDLESEXPLC  GLAXOSMITHKLINE10% Owner BRENTFORD MIDDLESEX,Sblendorio  GlenCranburySblendorio  GlennCranburySblendorio  GlennCranburyJeremy  GreenSAN FRANCISCOL STEPHEN  GREENWESTPORTDONALD J  HAYDEN JRDirector PRINCETONDONALD J  HAYDEN JRDirector CRANBURYDONALD J  HAYDEN JRDirector CRANBURYRUSSELL C  HIRSCHPALO ALTORUSSELL C  HIRSCHPALO ALTOBarrett  JamesCranburyBarrett  JamesCranburyTopper  JamesCranburyTopper  JamesCranburyGerskowitz  JayneCranburyCastelli  JeffreyCranburyCastelli  JeffreyCranburyWinterbottom  JoanCranburyCrowley  JohnCranburyCrowley  JohnCranburyMcAdam M  JohnVP, Finance & Accounting CRANBURYKirk  JohnCranburyKirk  JohnCranburyValenzano  KenCranburyValenzano  KenCranburyPeist  KennethCranburyJohn  KirkVP, Regulatory Affairs CRANBURYJohn  KirkVP, Regulatory Affairs CRANBURYKRISHNA KITTU  KOLLURIBALTIMOREKRISHNA KITTU  KOLLURITIMONIUMGREGORY  KOPCHINSKYWESTPORTC RICHARD  KRAMLICH10% Owner BALTIMOREC RICHARD  KRAMLICH10% Owner TIMONIUMGregory P  LicholaiVP, Medical Affairs CRANBURYCHARLES M  LINEHANBALTIMOREDavid J  LockhartChief Scientific Officer CRANBURYDavid J  LockhartChief Scientific Officer CRANBURYTED W  LOVEDirector SUNNYVALETED W  LOVEDirector CRANBURYKarin  LudwigCRANBURYPeter M  MacalusoVP & Corporate Counsel CRANBURYMcGlynn  MargaretCranburyMcGlynn  MargaretCranburyPatterson  MatthewCranburyMARGARET G  MCGLYNNDirector WHITEHOUSE STATIONMARGARET G  MCGLYNNDirector CRANBURYMARGARET G  MCGLYNNDirector CRANBURYRaab  MichaelCranburyRaab  MichaelCranburyRaab  MichaelCranburySinai School of Medicine of New York University  MountNEW YORKNEA 11 GP, LLCBALTIMORENEA 11 GP, LLCTIMONIUMNEA PARTNERS 11 LPBALTIMORENEA PARTNERS 11 LPTIMONIUMP SHERRILL  NEFFDirector PHILADELPHIAP SHERRILL  NEFFDirector PHILADELPHIANEW ENTERPRISE ASSOCIATES 11 LPBALTIMORENEW ENTERPRISE ASSOCIATES 11 LP10% Owner TIMONIUMCHARLES W  NEWHALL III10% Owner BALTIMORECHARLES W  NEWHALL III10% Owner TIMONIUMNeff  PCranburyDavid  PallingSr VP, Technical Operations CRANBURYMatthew R  PattersonActing CEO & President CRANBURYKenneth  PeistVP, Legal & IP CRANBURYKenneth  PeistVP, Legal & IP CRANBURYPERCEPTIVE ADVISORS LLC10% Owner WASHINGTONPERCEPTIVE ADVISORS LLC10% Owner NEW YORKPERCEPTIVE LIFE SCIENCES MASTER FUND LTDWASHINGTONMARK W  PERRY10% Owner BALTIMOREMARK W  PERRY10% Owner TIMONIUMBoudes  PolCranburyBoudes  PolCranburyPROSPECT ASSOCIATES II L PPALO ALTOPROSPECT ASSOCIATES II L PPALO ALTOPROSPECT MANAGEMENT CO II LLCPALO ALTOPROSPECT MANAGEMENT CO II LLCPALO ALTOPROSPECT VENTURE PARTNERS II LP10% Owner PALO ALTOPROSPECT VENTURE PARTNERS II LPPALO ALTOQUAKER BIO VENTURES LP10% Owner PHILADELPHIADaphne  QuimiSVP, Finance CRANBURYDaphne  QuimiVP Finance and Controller CRANBURYMICHAEL  RAABDirector BALTIMOREMICHAEL  RAABBALTIMOREMICHAEL  RAABDirector BALTIMOREMICHAEL  RAABDirector CRANBURYMICHAEL  RAABDirector CRANBURYRedmile Group, LLC10% Owner SAN FRANCISCOEssner  RobertCranburyWinkler  RobertCranburyEllen  RosenbergGeneral Counsel & Corp. Secy CRANBURYSETH  RUDNICKWESTPORTGUY M  RUSSOWESTPORTSchaeffer  SCranburySCOTT D  SANDELLBALTIMORESCOTT D  SANDELLTIMONIUMGLENN  SBLENDORIODirector NEW YORKGLENN  SBLENDORIODirector CRANBURYGLENN  SBLENDORIODirector CRANBURYOrlov S Nicole  SchaefferSVP, HR & Leadership Devt CRANBURYDAVID  SCHNELLPALO ALTODAVID  SCHNELLPALO ALTOAndrew  ShenkerVP, Clinical Research CRANBURYMark  SimonCRANBURYBarer  SolCranburyBarer  SolCranburyJAMES B  TANANBAUMPALO ALTOJAMES B  TANANBAUMPALO ALTOLove  TedCranburyLove  TedCranburyJames N  TopperDirector PALO ALTOJames N  TopperDirector PALO ALTOJames N  TopperDirector PALO ALTOJames N  TopperDirector PALO ALTOJames N  TopperDirector MENLO PARKEUGENE A  TRAINOR IIIBALTIMOREKen  ValenzanoSVP, Pharmacology & Biology CRANBURYKen  ValenzanoVP, Pharmacology & Biology CRANBURYGregory M  WeinhoffDirector STAMFORDGregory M  WeinhoffDirector STAMFORDCRAIG A  WHEELERDirector EMERYVILLEBaird,  William IIICranburyRobert E  WinklerVP, Clin Research & Operations CRANBURYRobert E  WinklerVP, Clin Research & Operations CRANBURYJoan  WinterbottomSVP, Human Resources CRANBURYERIC A  YOUNGWESTPORTJulie  YuVP Clinical Ops & Data Mgmt CRANBURYPersons related to Frazier Healthcare V, LP - GLAUKOS CorpNamePositionCityBRIAN G  ATWOODMENLO PARKOLAV  BERGHEIMDirector PRINCETONGeorge  BischofPALO ALTOJAMES C  BLAIRPRINCETONThomas William  BurnsChief Executive Officer LAGUNA HILLSChris M.  CalcaterraChief Commercial Officer LAGUNA HILLSBRUCE A  CLEVELANDSAN MATEOSAMUEL D  COLELLASANTA CLARATurner  DanielMenlo ParkASSOCIATES  DOMAINPRINCETONDOMAIN PARTNERS IV LP10% Owner PRINCETONDomain Partners VIII, L.P.10% Owner PRINCETONBRIAN H  DOVEYDP IV ASSOCIATES LP10% Owner PRINCETONDP VIII Associates, L.P.10% Owner BOSTONNathan R  EverySEATTLEFHM V, LLCSEATTLEFHM V, LPSEATTLEMark J  FoleyDirector PLEASANTONALAN D  FRAZIERSEATTLEPHILIP T  GIANOSKliman  GilbertMenlo ParkJoseph E  GilliamCFO, SVP Corporate Development SAN CLEMENTEMICHAEL B  GORDONBrian K  HalakPRINCETONRICHARD L  HARRISONCFO & Treasurer Patrick J  HeronPALO ALTODavid F  HoffmeisterDirector CARLSBADW Stephen  HolmesMENLO PARKInterWest Management Partners IX, LLC10% Owner MENLO PARKInterWest Partners IX, LPMENLO PARKSAMUEL D  ISALYROSS A MD  JAFFEMENLO PARKSilverstein  JonathanNew YorkKim P.  KamdarPRINCETONNina S  KjellsonMENLO PARKGilbert H  KlimanDirector MENLO PARKWILLIAM J PHD  LINKDirector SANTA ANABARBARA N  LUBASHMENLO PARKPAUL S  MADERADirector Chapekar  ManishMenlo ParkChapekar  ManishMenlo ParkMERITECH CAPITAL AFFILIATES III L PPALO ALTOMeritech Capital Associates III L.L.C.10% Owner PALO ALTOMeritech Capital Partners III LPPALO ALTODONALD B  MILDERMENLO PARKMontreux Equity Management IV, LLCSAN FRANCISCOMONTREUX EQUITY PARTNERS IV LP10% Owner SAN FRANCISCOMontreux IV Associates, LLCSAN FRANCISCOROBERT J  MOREDirector PRINCETONNader J  NainiSEATTLEKHALED  NASRSAN FRANCISCOBergheim  OlavLaguna HillsBergheim  OlavLaguna HillsORBIMED ADVISORS LLCDirector OrbiMed Capital GP III LLCNEW YORKARNOLD L  ORONSKYMENLO PARKMadera  PaulPalo AltoDouglas A  PepperMENLO PARKHarrison  RichardLaguna HillsMore  RobertMenlo ParkMore  RobertMenlo ParkREBECCA B  ROBERTSONKATHLEEN K  SCHOEMAKERPRINCETONJONATHAN  SILVERSTEINDirector NEW YORKMarc  StapleyDirector SAN DIEGOBurns  ThomasLaguna HillsJames N  TopperSEATTLEJESSE I  TREUPRINCETONVERSANT AFFILIATES FUND I-A LPMENLO PARKVERSANT AFFILIATES FUND I-B LPMENLO PARKVERSANT SIDE FUND I LPMENLO PARKVERSANT VENTURE CAPITAL I LPMENLO PARKVERSANT VENTURES I LLC10% Owner MENLO PARKNICOLE  VITULLORICHMONDRob  WardPALO ALTOAIMEE S  WEISNERDirector SANTA ANALink  WilliamNewport BeachPersons related to Frazier Healthcare V, LP - Tobira Therapeutics, Inc.NamePositionCityplc  ActavisPARSIPPANYAllergan Holdco US, Inc.IRVINEGopka  AntonBasking RidgeClark  B.Basking Ridge3, FCPR  BIODISCOVERY10% Owner PARISBIOTECHNOLOGY VALUE FUND II LPCHICAGOBIOTECHNOLOGY VALUE FUND L PCHICAGOBIOTECHNOLOGY VALUE FUND L PCHICAGOJAMES C  BLAIR10% Owner PRINCETONCarol L  BrosgartDirector SOUTH SAN FRANCISCOBVF INC/ILCHICAGOBVF PARTNERS L P/IL CHICAGOCourts  ChrisBasking RidgeB. Jefferson  ClarkDirector BASKING RIDGEB. Jefferson  ClarkDirector BASKING RIDGEB. Jefferson  ClarkDirector BASKING RIDGEJeffrey H  CooperDirector NOVATOChristopher  CourtsVice President of Finance BASKING RIDGEChristopher  CourtsVice President of Finance BASKING RIDGEMazzo  DavidBasking RidgePodlesak  DennisBasking RidgeASSOCIATES  DOMAIN10% Owner PRINCETONDOMAIN PARTERS VII L P10% Owner PRINCETONDomain Partners VI, L.P.10% Owner PRINCETONBRIAN H  DOVEYBRIAN H  DOVEY10% Owner PRINCETONDP VI Associates, L.P.10% Owner PRINCETONDP VII ASSOCIATES LP10% Owner PRINCETONDe Rothschild Investment Partners  EdmondPARISR Don  ElseySr. VP/Chief Financial Officer BASKING RIDGER Don  ElseySr. VP/Chief Financial Officer BASKING RIDGELaurent  FischerChief Executive Officer WATERTOWNAndrew J.  FromkinDirector BASKING RIDGEAndrew J.  FromkinDirector BASKING RIDGEDrew J  FromkinDirector NEWTONAlexander R  GiaquintoCCO and SVP of Reg. Affairs BASKING RIDGEAlexander R  GiaquintoCCO, SVP of Reg. Affairs BASKING RIDGEAnton  GopkaDirector BASKING RIDGEAnton  GopkaDirector BASKING RIDGEAnton  GopkaDirector BASKING RIDGEBrian K  HalakPRINCETONPatrick J  HeronDirector PALO ALTOClark  JeffBasking RidgeHelen  JenkinsChief Operating Officer SOUTH SAN FRANCISCOTreu  JesseBasking RidgeKim P.  KamdarPRINCETONROBERT A  KIERLIN10% Owner WINONAROBERT A  KIERLIN10% Owner WINONAMARK N  LAMPERTSAN FRANCISCOEric  LefebvreChief Medical Officer SOUTH SAN FRANCISCOPierre  LegaultDirector BERKELEY HEIGHTSPierre  LegaultDirector BASKING RIDGEPierre  LegaultBASKING RIDGEDavid J  MazzoPresident and CEO BASKING RIDGEDavid J  MazzoChief Executive Officer BASKING RIDGEEllen  McDonaldSVP & Chief Business Officer BASKING RIDGEGwen A  MelincoffDirector SOUTH SAN FRANCISCOMichael  MendelsohnBASKING RIDGEMichael  MendelsohnDirector BASKING RIDGEMichael  MendelsohnDirector BASKING RIDGEMichael A  MetzgerPresident and COO BASKING RIDGEMichael A  MetzgerPresident & CEO BASKING RIDGEMendelsohn  MichaelBasking RidgeMetzger  MichaelBasking RidgeP SHERRILL  NEFFDirector BASKING RIDGEP SHERRILL  NEFFPHILADELPHIAP SHERRILL  NEFFDirector PHILADELPHIAA/S  Novo10% Owner BAGSVAERDNeff  P.Basking RidgeChristopher  PeetzChief Financial Officer SOUTH SAN FRANCISCONicholas J.  PelliccioneSr. VP of Regulatory Affairs BASKING RIDGEPentwater Capital Management LP10% Owner CHICAGOLegault  PierreBasking RidgeDennis  PodlesakDirector SAN DIEGODennis  PodlesakDirector BASKING RIDGEDennis  PodlesakDirector BASKING RIDGEDennis  PodlesakDirector BASKING RIDGEQUAKER BIO VENTURES LP10% Owner PHILADELPHIAQUAKER BIOVENTURES CAPITAL LPPHILADELPHIAWishiewski  RaphaelBasking RidgeWisniewski  RaphaelBasking RidgeInvestments S.a.r.l.  RMILUXEMBOURGInvestments S.a.r.l.  RMI10% Owner MOSCOWChristopher Paul  RusconiDURHAMChristopher Paul  RusconiChief Scientific Officer BASKING RIDGEChristopher Paul  RusconiChief Scientific Officer BASKING RIDGERusnanoMedInvest LLCMOSCOWRusnanoMedInvest LLCMOSCOWSapphire Acquisition Corp.PARSIPPANYKATHLEEN K  SCHOEMAKER10% Owner PRINCETONNimesh  ShahPRINCETONJESSE I  TREUDirector PRINCETONNICOLE  VITULLORICHMONDNICOLE  VITULLO10% Owner PRINCETONECKARD  WEBERDirector SOUTH SAN FRANCISCORaphael  WisniewskiDirector BASKING RIDGERaphael  WisniewskiDirector BASKING RIDGESteven  ZelenkofskeSVP & Chief Medical Officer BASKING RIDGESteven  ZelenkofskeSVP & Chief Medical Officer BASKING RIDGEPersons related to Frazier Healthcare V, LP - CADENCE PHARMACEUTICALS INCNamePositionCityHAZEL M  AKERSVP, GC & Secretary SAN DIEGOBRIAN G  ATWOODDirector SAN DIEGOBRIAN G  ATWOODDirector SAN DIEGOSAM L  BARKERSAN DIEGOSAM L  BARKERDirector SAN DIEGOMichael A  BermanDirector SAN DIEGOMichael A  BermanDirector SAN DIEGOJAMES C  BLAIRDirector PRINCETONJAMES B  BREITMEYEREVP, CMO SAN DIEGOScott A.  ByrdSVP, Chief Commercial Officer SAN DIEGOWILLIAM S  CRAIGSVP SAN DIEGOLAUREEN  DEBUONODirector SAN DIEGOASSOCIATES  DOMAIN10% Owner PRINCETONDOMAIN PARTERS VII L P10% Owner PRINCETONDomain Partners VI, L.P.10% Owner PRINCETONDomain Partners VI, L.P.10% Owner PRINCETONBRIAN H  DOVEY10% Owner PRINCETONDP VI Associates, L.P.10% Owner PRINCETONDP VII ASSOCIATES LP10% Owner PRINCETONMICHAEL L  EAGLEDirector SAN DIEGOFHM V, LLCSEATTLEFHM V, LPSEATTLEFHM VI, L.L.C.SEATTLEFHM VI, L.P.SEATTLEALAN D  FRAZIERDirector SAN DIEGOFrazier Healthcare VI, L.P.SEATTLECAM L  GARNERDirector SAN DIEGOBrian K  Halak10% Owner PRINCETONKim P.  Kamdar10% Owner PRINCETONWILLIAM R  LARUESVP, CFO, Treas, Asst Sec SAN DIEGOMalcolm  Lloyd-SmithSVP, Reg Affairs, Qual & Clin SAN DIEGORichard E  LowenthalVP SAN DIEGOJay  MoorinPRINCETONJay  MoorinPRINCETONROBERT J  MORE10% Owner PRINCETONROBERT J  MOREPRINCETONStephen L  NewmanDirector SAN DIEGOProQuest Associates III LLCPRINCETONProQuest Associates III LLCPRINCETONProQuest Investments III, L.P.10% Owner PRINCETONProQuest Investments III, L.P.10% Owner PRINCETONProQuest Management LLCPRINCETONProQuest Management LLCPRINCETONProQuest Management LLCPRINCETONTodd W  RichDirector SAN DIEGOMike A  RoyalVP SAN DIEGOKATHLEEN K  SCHOEMAKER10% Owner PRINCETONALAIN  SCHREIBERPRINCETONALAIN  SCHREIBERPRINCETONALAIN  SCHREIBERSAN DIEGOTheodore R  SchroederPresident, CEO SAN DIEGODavid A  SocksSVP SAN DIEGOJESSE I  TREU10% Owner PRINCETONJESSE I  TREU10% Owner PRINCETONCHRISTOPHER J  TWOMEYDirector SAN DIEGONICOLE  VITULLO10% Owner PRINCETONPersons related to Frazier Healthcare V, LP - ANAPTYSBIO INCNamePositionCityAVALON VENTURES VII GP, LLCLA JOLLAAvalon Ventures VII L P10% Owner LA JOLLAGallagher  CarolSan DiegoGallagher  CarolSan DiegoNathan R  EverySEATTLEFHM V, LLCSEATTLEFHM V, LPSEATTLEFHM VII, L.L.C.SEATTLEFHM VII, L.P.SEATTLEALAN D  FRAZIERSEATTLEFrazier Healthcare VII-A, L.P.SEATTLEFrazier Healthcare VII, L.P.10% Owner SEATTLECarol Giltner  GallagherDirector CARLSBADSuria  HamzaSan DiegoSuria  HamzaSan DiegoLukatch  HeathSan DiegoLukatch  HeathSan DiegoLukatch  HeatheSan DiegoPatrick J  HeronPALO ALTORenton  HollingsSan DiegoRead  J.San DiegoRead  J.San DiegoTopper  JamesSan DiegoTopper  JamesSan DiegoTopper  JamesSan DiegoSchmid  JohnSan DiegoKinsella  KevinSan DiegoKinsella  KevinSan DiegoKevin J  KinsellaSAN DIEGOMarco  LondeiChief Medical Officer SAN DIEGONicholas  LydonDirector CAMBRIDGELondei  MarcoSan DiegoMATTHEW  MOYLEChief Scientific Officer HOUSTONNader J  NainiSEATTLELydon  NicholasSan DiegoLydon  NickSan DiegoLydon  NickSan DiegoA/S  Novo10% Owner BAGSVAERDDominic  PiscitelliChief Financial Officer SAN DIEGOHOLLINGS  RENTONDirector Hoffman  RobertSan DiegoJohn P.  SchmidDirector SAN DIEGOJames A  SchoeneckDirector MENLO PARKHamza  SuriaPresident, CEO SAN DIEGOSmart  ThomasSan DiegoAynechi  TibaSan DiegoStephen Lawrence  TomlinLA JOLLAJames N  TopperDirector SEATTLEPersons related to Frazier Healthcare V, LP - Zeltiq Aesthetics IncNamePositionCityAdvanced Technology Ventures VII(B), L.P.WALTHAMAdvanced Technology Ventures VII(B), L.P.BOSTONAdvanced Technology Ventures VII(C), L.P.WALTHAMAdvanced Technology Ventures VII(C), L.P.BOSTONADVANCED TECHNOLOGY VENTURES VII LPWALTHAMADVANCED TECHNOLOGY VENTURES VII LPBOSTONAISLING CAPITAL III LPNEW YORKAisling Capital Partners III LLCNEW YORKAisling Capital Partners III LPNEW YORKSteven W  AtkinsonSVP of International PLEASANTONSteven W  AtkinsonSVP of International PLEASANTONATV Associates VII, L.L.C.WALTHAMATV Associates VII, L.L.C.10% Owner BOSTONATV Entrepreneurs VII, L.P.WALTHAMATV Entrepreneurs VII, L.P.BOSTONJoshua T  BrummVP of Corporate Development PLEASANTONLeonard C  DeBenedictisChief Technical Officer HAYWARDLeonard C  DeBenedictisChief Technical Officer PLEASANTONLeonard C  DeBenedictisChief Technology Officer PLEASANTONLeonard C  DeBenedictisChief Technology Officer PLEASANTONSTEVE  ELMSNEW YORKSTEVE  ELMSNEW YORKDavid J.  EndicottDirector IRVINEFHM V, LLCSEATTLEFHM V, LLCSEATTLEFHM V, LPSEATTLEFHM V, LPSEATTLEMARY  FISHERDirector HAWTHORNEMARY  FISHERDirector PLEASANTONMARY  FISHERDirector PLEASANTONMARY  FISHERDirector PLEASANTONMike  FitzgeraldSr. VP, Global HR SUNNYVALEMark J  FoleyPresident and CEO PLEASANTONMark J  FoleyPresident and CEO PLEASANTONMark J  FoleyPresident and CEO PLEASANTONSergio  GarciaSenior VP, GC & Secretary SAN DIEGOSergio  GarciaSenior VP, GC & Secretary PLEASANTONSergio  GarciaSVP, GC & Corporate Secretary PLEASANTONMichael  GenauPres, N American Franchise PLEASANTONJean  GeorgeDirector LEXINGTONJean  GeorgeWALTHAMJean  GeorgeDirector BOSTOND KEITH  GROSSMANDirector D KEITH  GROSSMANDirector PLEASANTOND KEITH  GROSSMANDirector PLEASANTONTaylor C.  HarrisSVP & Chief Financial Officer PLEASANTONDanika R  HarrisonSVP of Global Marketing PLEASANTONBradley  HauserSVP, Research and Development PLEASANTONBrent  HauserPresident, North America PLEASANTONDavid H  HeagyFormer VP of N American Sales PLEASANTONJohn F  HoweCFO and Sr. VP PLEASANTONDennis J  JarvisChief Marketing Officer PLEASANTONCarl  LammSVP of Operations PLEASANTONCarl  LammVP of Operations PLEASANTONCarl  LammVP of Operations PLEASANTONGordon E  NyeFormer CEO and President PLEASANTONKEVIN C  OBOYLEDirector SAN DIEGOKEVIN C  OBOYLEDirector PLEASANTONKEVIN C  OBOYLEDirector PLEASANTONKEVIN C  OBOYLEDirector CARLSBADKEVIN C  OBOYLEDirector SAN DIEGORichard W  PoinsettSVP of Operations PLEASANTONRichard W  PoinsettSVP of Operations PLEASANTONDennis J  PurcellNEW YORKDennis J  PurcellNEW YORKBRYAN E  ROBERTSDirector MENLO PARKBRYAN E  ROBERTSDirector PALO ALTOBRYAN E  ROBERTSPALO ALTOANDREW N  SCHIFFDirector NEW YORKANDREW N  SCHIFFDirector NEW YORKANDREW N  SCHIFFDirector NEW YORKDR DREW  SCHIFFDirector NEW YORKRobert Bernard  StockmanPLEASANTONKeith J  SullivanCCO, President, North America PLEASANTONKeith J  SullivanSVP of WW Sales and Marketing PLEASANTONKeith J  SullivanSVP of WW Sales and Marketing PLEASANTONKristine N  TatsutaniCSO, SVP of Reg., Clinic & QA PLEASANTONKristine N  TatsutaniCSO, SVP of Reg.,Clinical & QA PLEASANTONVEF Management V, LLCPALO ALTOVEF Management V, LLCPALO ALTOVENROCK ASSOCIATES V LP10% Owner PALO ALTOVENROCK ASSOCIATES V LPPALO ALTOVenrock Entrepreneurs Fund V, L.P.PALO ALTOVenrock Entrepreneurs Fund V, L.P.PALO ALTOVenrock Management V, LLCPALO ALTOVenrock Management V, LLCPALO ALTOVenrock Partners Management V, LLCPALO ALTOVenrock Partners Management V, LLCPALO ALTOVENROCK PARTNERS V L PPALO ALTOVENROCK PARTNERS V L PPALO ALTOIan P  WestVP of Product Development PLEASANTONPatrick F.  WilliamsSVP & CFO PLEASANTONPatrick F.  WilliamsSVP, Chief Financial Officer PLEASANTONPatrick F.  WilliamsSVP, Chief Financial Officer PLEASANTONTodd Erik  ZavodnickPresident, International PLEASANTONZeltiq Aesthetics IncSenior VP, GC & Secretary PLEASANTON
Potentially same personNameCityCountryFrazier Healthcare V, LPSEATTLEWAFrazier Healthcare V, LPSEATTLEWA












 






